What insurance policy changes affect CPT 64561?

There are 10 tracked policy changes affecting CPT 64561, including updates from Blue Cross and Blue Shield of Minnesota, Harvard Pilgrim Health Care, Health Net. Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

How do I get notified when CPT 64561 policy changes?

Create a free account at PolicyChanges.app and save a search filtered to CPT 64561. You will receive a daily digest email whenever a new policy change references this code.

Why do payers change policies for CPT 64561?

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

64561 — A surgical procedure where electrodes are placed in nerves to send electrical signals for pain relief or nerve stimulation therapy.: Insurance Policy Changes

Q: Which payers have updated policy for CPT 64561?

Payers that have issued tracked updates for CPT 64561 include: Blue Cross and Blue Shield of Minnesota, Harvard Pilgrim Health Care, Health Net, Aetna, Humana, Excellus BlueCross BlueShield.

64561 Insurance Policy Changes

CPT 64561, in plain terms, covers A surgical procedure where electrodes are placed in nerves to send electrical signals for pain relief or nerve stimulation therapy. CPT 64561 is referenced in 10 tracked payer policy changes from Blue Cross and Blue Shield of Minnesota, Harvard Pilgrim Health Care, and 4 other payers. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for CPT 64561 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Medium impact

Pelvic Congestion Syndrome Treatments (CPB 0441, reviewed 2026-07-09)

Aetna·Effective Jul 9, 2026

Aetna's updated Clinical Policy Bulletin 0441 (effective 2026-07-09) establishes coverage criteria for pelvic congestion syndrome treatments, covering gonadal/ovarian vein embolization ONLY when patients have definitive diagnostic imaging (CT/MRI/venography) AND have failed appropriate pharmacotherapy. Median sacral vein embolization, sacral nerve neuromodulation, ovarian vein transposition, and micronized purified flavonoid fraction remain non-covered as experimental/investigational. Billing teams must verify both criteria are met before authorizing claims.

64561 Insurance Policy Changes

Upcoming Policies effective September 7, 2026

Point32Health Medical Necessity Guideline updates

26-073 Updates to the Prior Authorization Requirements

26-074 Updates to the Prior Authorization Requirements

26-075 Updates to the Prior Authorization Requirements

Updated billing requirements effective Jan. 1, 2026

Pelvic Congestion Syndrome Treatments (CPB 0441, reviewed 2026-07-09)

Nerve Stimulation for Urinary Incontinence - Medicare Advantage (Revised)

Nerve Stimulation for Fecal Incontinence - Medicare Advantage (Revised)

Electrical Stimulation as a Treatment for Pain and Other Medical Conditions 1.01.55